TransPharma Medical
Specialty pharmaceutical company focused on the development and commercialization of drug-products
About TransPharma Medical
Established in 2000, TransPharma Medical Ltd. was a specialty pharmaceutical company headquartered in Lod, Israel, that concentrated on creating and marketing drug products using its active transdermal drug delivery technology. The company's business model revolved around forming strategic partnerships with major pharmaceutical firms and pursuing independent product development to bring multiple drug products to market.
The core of TransPharma Medical's offering was the ViaDerm system, a technology designed for the transdermal delivery of medications. This system utilized a handheld, reusable electronic device that employed radiofrequency energy to create microscopic channels (RF-MicroChannels) in the skin's outer layer. This process enabled the subsequent delivery of a broad range of drugs, including hydrophilic small molecules, peptides, and proteins, through a specialized patch applied to the treated area. The medication would then passively diffuse through these microchannels into the bloodstream. The ViaDerm system, which received CE Mark approval, was developed for both self-administered home use and in-office applications, designed to be a virtually painless and easy-to-use alternative to injections.
Throughout its operation, TransPharma Medical successfully raised capital to fund its research and development. The company secured a total of $33.4 million in funding from investors, including Evergreen Venture Partners, Pitango Venture Capital, Teva Pharmaceuticals, and SCP Vitalife Partners. Its clinical pipeline included a product for osteoporosis, developed in collaboration with Eli Lilly, which advanced to Phase 2b studies, as well as a GLP-1 agonist for type II diabetes. A significant milestone was the successful completion of a Phase 1 trial for its self-applied ViaDerm system. In March 2012, Syneron Medical Ltd. (later acquired by Candela Medical) acquired substantially all of TransPharma Medical's assets, including its extensive patent portfolio, for approximately $3.6 million.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2012 | $0 | — | Syneron Medical | — |
| SERIES C✓Equity / VC | Jul 2006 | $18M | $72M | T2C2 Capital · Argonaut Private Equity · Pitango Venture Capital · Agronaut Private Equity | — |
Growth signals
Latest recorded traffic for TransPharma Medical is 260 monthly website visits, up 225% over the last three months. TransPharma Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Nisha ExecutiveExecutive search for senior and board-level positions. |
Tel Aviv-Yafo, Israel | Operational | 9 | — | — |
Larry Miller PhD Career Partners LLC (LarryMillerPhD.com)Career coaching for life scientists and science communicators in biotechnology and pharma sectors |
Washington DC, United States | Operational | |||
RedeploymentJobs Recruitment |
San Diego, United States | Operational | |||
Clark executive search incGrowth for Businesses and Individuals |
Town of Shelter Island, United States | Operational | |||
Business of ScienceThe Business of Science Startup Index Score | The Business of Science |
Cambridge, United States | Operational | |||
StoneStableSilica-based coating technology for ambient temperature vaccine stabilization |
Portland, United States | Low Activity | |||
HYF GroupHYF Group markets, develops and produces biometric hardware |
Shenzhen, China | Operational | |||
TuSionTusion — Tune Your Vision |
New York City, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
TransPharma Medical in the Kochav Yair ecosystem
The TransPharma Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Pitango Venture Capital- BIBiomedical Investments
Evergreen Venture Partners
Series B and later3 investors entered at this stage
Agronaut Private Equity- TCT2C2 Capital
Argonaut Private Equity
Other known investors1 additional known investor
Syneron Medical
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TransPharma Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TransPharma Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







